UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Association of albumin, fibrinogen, and modified proteins with acute coronary syndrome

PloS one, 2022-07, Vol.17 (7), p.e0271882-e0271882

2022

Volltextzugriff (PDF)

Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

Cardiovascular diabetology, 2022-05, Vol.21 (1), p.77-12, Article 77

2022

Volltextzugriff (PDF)

The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy

Mediators of inflammation, 2017-01, Vol.2017, p.5620314-13

2017

Volltextzugriff (PDF)

Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea

PloS one, 2022-07, Vol.17 (7), p.e0270838-e0270838

2022

Volltextzugriff (PDF)

Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome

PloS one, 2022-05, Vol.17 (5), p.e0267433-e0267433

2022

Volltextzugriff (PDF)

Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease

Reviews in cardiovascular medicine, 2021-09, Vol.22 (3), p.755-768

2021

Volltextzugriff (PDF)

Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long‐term inhibition

BioFactors (Oxford), 2020-05, Vol.46 (3), p.367-380

2020

Volltextzugriff (PDF)

Antithrombotic Therapy After TAVI: Evidence, Discordance, and Clinical Implications

Current vascular pharmacology, 2022-01, Vol.20 (4), p.318

2022

Volltextzugriff (PDF)

Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies

Journal of cardiovascular medicine (Hagerstown, Md.), 2021-03, Vol.22 (3), p.151

2021

Volltextzugriff (PDF)

SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction

Critical care (London, England), 2021-06, Vol.25 (1), p.1-217, Article 217

2021

Volltextzugriff (PDF)

Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target

Monaldi archives for chest disease, 2021-05, Vol.91 (2)

2021

Volltextzugriff (PDF)

The Biological Role of Vitamins in Athletes' Muscle, Heart and Microbiota

International journal of environmental research and public health, 2022-01, Vol.19 (3), p.1249

2022

Volltextzugriff (PDF)

Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex Combination

International journal of environmental research and public health, 2021-01, Vol.18 (3), p.904

2021

Volltextzugriff (PDF)

Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice

International journal of molecular sciences, 2023-04, Vol.24 (9), p.8099

2023

Volltextzugriff (PDF)

Insulin Resistance/Hyperinsulinemia as an Independent Risk Factor That Has Been Overlooked for Too Long

Biomedicines, 2024-06, Vol.12 (7), p.1417

2024

Volltextzugriff (PDF)

Reply to SGLT-2 inhibitors: Post-infarction interventional effects

Pharmacological research, 2023-03, Vol.189, p.106664-106664, Article 106664

2023

Volltextzugriff (PDF)

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

Frontiers in cardiovascular medicine, 2022-09, Vol.9, p.1012220-1012220

2022

Volltextzugriff (PDF)

Rheumatic mitral stenosis in a 28-week pregnant woman treated by mitral valvuoplasty guided by low dose of radiation: a case report and brief overview

General thoracic and cardiovascular surgery, 2021-02, Vol.69 (2), p.364-366

2021

Volltextzugriff (PDF)

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention

Journal of clinical medicine, 2022-06, Vol.11 (13), p.3574

2022

Volltextzugriff (PDF)

Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry

Internal and emergency medicine, 2021-03, Vol.16 (2), p.379-387

2021

Volltextzugriff (PDF)

Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options

Frontiers in cardiovascular medicine, 2023-07, Vol.10, p.1187735-1187735

2023

Volltextzugriff (PDF)

Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome

Internal and emergency medicine, 2021-09, Vol.16 (6), p.1583-1591

2021

Volltextzugriff (PDF)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective

Journal of clinical medicine, 2023-04, Vol.12 (8), p.2810

2023

Volltextzugriff (PDF)

Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Journal of clinical medicine, 2023-12, Vol.13 (1), p.98

2023

Volltextzugriff (PDF)

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice

Journal of clinical medicine, 2022-10, Vol.11 (21), p.6246

2022

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

ThemaHeart Failure

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(105)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Association of albumin, fibrinogen, and modified proteins with acute coronary syndrome

Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy

Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea

Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome

Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease

Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long‐term inhibition

Antithrombotic Therapy After TAVI: Evidence, Discordance, and Clinical Implications

Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies

SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction

Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target

The Biological Role of Vitamins in Athletes' Muscle, Heart and Microbiota

Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex Combination

Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice

Insulin Resistance/Hyperinsulinemia as an Independent Risk Factor That Has Been Overlooked for Too Long

Reply to SGLT-2 inhibitors: Post-infarction interventional effects

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

Rheumatic mitral stenosis in a 28-week pregnant woman treated by mitral valvuoplasty guided by low dose of radiation: a case report and brief overview

Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention

Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry

Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options

Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective

Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice

Aktive Filter

Suchergebnisse filtern